Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.1mm RC, SLA? 14mm, Ti, Loxim: medical device reports filed with FDA

1,971 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,971
device reports naming the brand
0% of all MAUDE reports · about 285 a year
376
reports, 12 months to August 2026
445 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,971 reports that name the brand "BLT ?4.1mm RC, SLA? 14mm, Ti, Loxim" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

376 reports arrived in the 12 months to August 2026, down 16% from 445 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (87.3%), loss of osseointegration (9.9%) and fracture (0.4%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

067133Sep 2021: 18Oct 2021: 13Nov 2021: 18Dec 2021: 122022Jan 2022: 17Feb 2022: 7Mar 2022: 12Apr 2022: 19May 2022: 27Jun 2022: 15Jul 2022: 22Aug 2022: 17Sep 2022: 16Oct 2022: 22Nov 2022: 28Dec 2022: 162023Jan 2023: 10Feb 2023: 10Mar 2023: 17Apr 2023: 36May 2023: 41Jun 2023: 24Jul 2023: 29Aug 2023: 28Sep 2023: 33Oct 2023: 29Nov 2023: 47Dec 2023: 292024Jan 2024: 33Feb 2024: 35Mar 2024: 31Apr 2024: 40May 2024: 32Jun 2024: 33Jul 2024: 47Aug 2024: 32Sep 2024: 37Oct 2024: 26Nov 2024: 44Dec 2024: 352025Jan 2025: 35Feb 2025: 28Mar 2025: 29Apr 2025: 15May 2025: 0Jun 2025: 133Jul 2025: 27Aug 2025: 36Sep 2025: 64Oct 2025: 26Nov 2025: 38Dec 2025: 302026Jan 2026: 35Feb 2026: 15Mar 2026: 16Apr 2026: 20May 2026: 19Jun 2026: 41Jul 2026: 39Aug 2026: 33

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02314612019: 7120192020: 7920202021: 16620212022: 21820222023: 33320232024: 42520242025: 46120252026: 2182026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,971
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report93%1,834
Voluntary report0%0
User facility report0%0
Distributor report7%137
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,72087.3%62.8%
Loss of osseointegration1959.9%22.4%
Fracturea broken bone70.4%1.6%
Difficult to insertthe device was hard to insert50.3%0.4%
Patient-device incompatibilitythe device did not suit the patient10.1%0%
Unintended movement10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis44322.5%
Painpain, site not specified33817.1%
Inflammationinflammation944.8%
Tissue damage773.9%
Swelling/ edema713.6%
Hemorrhage/blood loss/bleeding613.1%
Fistula321.6%
Abscessa collection of pus201%
Hyperresponsive to stimuli191%
Inadequate osseointegration110.6%
Swellingswelling90.5%
Hypersensitivity/allergic reaction80.4%
Failure of implant70.4%
Increased sensitivity60.3%
Numbnessnumbness60.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.1mm RC, SLA? 14mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports1,9713,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer93%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.1mm RC, SLA? 14mm, Ti, Loxim reports

How many FDA reports name BLT ?4.1mm RC, SLA? 14mm, Ti, Loxim?

1,971 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 376 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (87.3%), loss of osseointegration (9.9%), fracture (0.4%), difficult to insert (0.3%) and patient-device incompatibility (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (93%) and distributor reports (7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.1mm RC, SLA? 14mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.